Treatment Treatment

When it comes to deal rosy, time is the main criterion.

Although treatment hinders the progress of the disease, it cannot reverse disabilities, especially some that are too severe to be restored surgically. Thus, early diagnosis is a must to prevent any permanent damage.

As of 2018, the World Health Organization has shared the newest recommended treatment guidelines for Leprosy: Multidrug Therapy consisting of different dosages of They are available in blister packs, each containing specific dosages for four weeks’ worth of medication based on the patient’s age. Children who weigh less than 40 kilograms have to take single formulation medications since no combinations are available.

Rifampicin

The duration of treatment also varies based on the patient’s condition and whether he or she is suffering from a Paucibacillary Leprosy or a Multibacillary Leprosy, the first requiring 6 months of treatment while the latter 12 months of treatment.

The recommended dosages as per the 2018 WHO Guidelines for the Diagnosis, Treatment, and Prevention of Leprosy are listed as follows:

Adults

Rifampicin 600mg once a month

Clofazimine 300mg once a month and 50mg daily

Dapsone 100mg daily

Children (10-14 years old)

Rifampicin 450mg once a month

Clofazimine 150mg once a month and 50mg every other day

Dapsone 50mg daily

Children < 10 years old or <40kg

Rifampicin 10mg/kg once a month

Clofazimine 100mg once a month and 50mg twice per week

Dapsone 2mg/kg daily